Tags: Drug.

UR-144 (TMCP-018 KM-X1 MN-001 YX-17) is a drug invented by Abbott Laboratories that acts as a selective full agonist of the peripheral cannabinoid receptor CB2 but with much lower affinity for the psychoactive CB1 receptor.

Loading...

This page contains content from the copyrighted Wikipedia article "UR-144"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.